Cumba, Carmen G.
HRN: 17-34-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2025
CLINDAMYCIN 300MG (CAP)
03/17/2025
03/19/2025
ORAL
600mg
Every 8hrs
Non Healing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes